Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

8 Dec 2017 16:41

RNS Number : 8772Y
Genus PLC
08 December 2017
 

8 December 2017

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional shares on 20 November 2017 under the Genus 2014 Performance Share Plan ('PSP') as listed in table A below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 22 November 2017 on the London Stock Exchange to partly offset income tax and social security liabilities due on the exercise. This exercise and sale was inadvertently not included in the announcement made on 23 November 2017.

 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of conditional shares exercised and ordinary shares sold on 22 November 2017.

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

2.

Reason for the notification

a.

Position/status

Group Human Resources Director

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 829 conditional shares under the PSP.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

829

 

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of 829 shares arising from the exercise of conditional shares under the PSP partly to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,185.42p

829

d.

Aggregated information

· Aggregated volume

· Price

 

 

Aggregated price(s)

 

Total volume(s)

2,185.42p

829

e.

Date of the transaction

2017-11-22

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUWONRBKAURAA
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.